Inhibition of the visual cycle by A2E through direct interaction with RPE65 and implications in Stargardt disease
- PMID: 20876139
- PMCID: PMC2955102
- DOI: 10.1073/pnas.1008769107
Inhibition of the visual cycle by A2E through direct interaction with RPE65 and implications in Stargardt disease
Abstract
Stargardt disease (STGD) is the major form of inherited juvenile macular degeneration. Pyridinium bis-retinoid A2E is a major component of lipofuscin which accumulates in retinal pigment epithelium (RPE) cells in STGD and contributes to the disease pathogenesis. However, the precise role of A2E in vision loss is unclear. Here we report that A2E efficiently inhibits RPE65 isomerohydrolase, a key enzyme in the visual cycle. Subretinal injection of A2E significantly inhibited retinoid isomerohydrolase activity in mice. Likewise, A2E also inhibited isomerohydrolase activity in cells coexpressing RPE65, lecithin retinol acyltransferase (LRAT), and cellular retinaldehyde-binding protein. In vitro isomerohydrolase activity assays confirmed that A2E inhibited enzymatic activity of recombinant RPE65 in a concentration-dependent manner, but did not inhibit LRAT activity. The inhibition type for isomerohydrolase was found to be reversible and competitive with K(i) = 13.6 μM. To determine the direct interaction of A2E with RPE65 protein, fluorescence binding assays were performed. As shown by fluorimetric titration, binding of purified RPE65 with A2E enhanced the bis-retinoid fluorescence. Consistently, the fluorescence of RPE65 decreased upon incubation with A2E. Both of these experiments suggest a direct, specific binding of A2E to RPE65. The binding constant for A2E and purified RPE65 was calculated to be 250 nM. These results demonstrate that A2E inhibits the regeneration of 11-cis retinal, the chromophore of visual pigments, which represents a unique mechanism by which A2E may impair vision in STGD.
Conflict of interest statement
The authors declare no conflict of interest.
Figures





Similar articles
-
The novel visual cycle inhibitor (±)-RPE65-61 protects retinal photoreceptors from light-induced degeneration.PLoS One. 2022 Oct 13;17(10):e0269437. doi: 10.1371/journal.pone.0269437. eCollection 2022. PLoS One. 2022. PMID: 36227868 Free PMC article.
-
The all-trans-retinal dimer series of lipofuscin pigments in retinal pigment epithelial cells in a recessive Stargardt disease model.Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19273-8. doi: 10.1073/pnas.0708714104. Epub 2007 Nov 28. Proc Natl Acad Sci U S A. 2007. PMID: 18048333 Free PMC article.
-
Rpe65 Leu450Met variant is associated with reduced levels of the retinal pigment epithelium lipofuscin fluorophores A2E and iso-A2E.Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11668-72. doi: 10.1073/pnas.0403499101. Epub 2004 Jul 26. Proc Natl Acad Sci U S A. 2004. PMID: 15277666 Free PMC article.
-
Retinal pigment epithelium 65 kDa protein (RPE65): An update.Prog Retin Eye Res. 2022 May;88:101013. doi: 10.1016/j.preteyeres.2021.101013. Epub 2021 Oct 2. Prog Retin Eye Res. 2022. PMID: 34607013 Free PMC article. Review.
-
A2E, a byproduct of the visual cycle.Vision Res. 2003 Dec;43(28):2983-90. doi: 10.1016/s0042-6989(03)00475-9. Vision Res. 2003. PMID: 14611934 Review.
Cited by
-
Allelic and phenotypic heterogeneity in ABCA4 mutations.Ophthalmic Genet. 2011 Sep;32(3):165-74. doi: 10.3109/13816810.2011.565397. Epub 2011 Apr 21. Ophthalmic Genet. 2011. PMID: 21510770 Free PMC article. Review.
-
Membrane receptors and transporters involved in the function and transport of vitamin A and its derivatives.Biochim Biophys Acta. 2012 Jan;1821(1):99-112. doi: 10.1016/j.bbalip.2011.06.010. Epub 2011 Jun 17. Biochim Biophys Acta. 2012. PMID: 21704730 Free PMC article. Review.
-
Morphological and physiological retinal degeneration induced by intravenous delivery of vitamin A dimers in rabbits.Dis Model Mech. 2015 Feb;8(2):131-8. doi: 10.1242/dmm.017194. Epub 2014 Dec 12. Dis Model Mech. 2015. PMID: 25504631 Free PMC article.
-
Retinoic Acid Receptor Beta in Pathophysiology of Age-Related Macular Degeneration.Iran J Public Health. 2015 Nov;44(11):1570-1. Iran J Public Health. 2015. PMID: 26744723 Free PMC article. No abstract available.
-
Genetic determinants of macular pigments in women of the Carotenoids in Age-Related Eye Disease Study.Invest Ophthalmol Vis Sci. 2013 Mar 28;54(3):2333-45. doi: 10.1167/iovs.12-10867. Invest Ophthalmol Vis Sci. 2013. PMID: 23404124 Free PMC article.
References
-
- Stargardt K. Über familiäre, progressive Degeneration in der Maculagegend des Auges. Graef Arch Clin Exp. 1909;71:534–550.
-
- Blacharski PA. Fundu flavimaculatus. In: Newsome DA, editor. Retinal Dystrophies and Degenerations. New York: Raven; 1988. pp. 135–159.
-
- Fishman GA, Farber M, Patel BS, Derlacki DJ. Visual acuity loss in patients with Stargardt’s macular dystrophy. Ophthalmology. 1987;94:809–814. - PubMed
-
- Noble KG, Carr RE. Stargardt’s disease and fundus flavimaculatus. Arch Ophthalmol. 1979;97:1281–1285. - PubMed
-
- Allikmets R, et al. A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet. 1997;15:236–246. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous